Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis — Stella

Home/Relapsing Remitting Multiple Sclerosis (RRMS)/Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis

View on ClinicalTrials.gov

Recruiting

Back to Relapsing Remitting Multiple Sclerosis (RRMS) trials

Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

Glostrup Hospital, Glostrup Municipality

Key details

Sponsor

Glostrup University Hospital, Copenhagen

Collaborators

University of Copenhagen, University of Southampton

Enrollment target

~220 participants

Started

January 2026

Primary completion

July 2028

Age range

18 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.